Bo Lu MD
Thoracic Cancer
Professor and Chair, Department of Radiation Oncology, University of Missouri in Columbia.
Join to View Full Profile
1 Hospital DrColumbia, MO 65212
Phone+1 573-884-7770
Fax+1 573-882-9876
Dr. Lu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Bo Lu is a respected Radiation Oncology specialist based in Columbia, MO. He has a subspecialty in Thoracic Cancer and a proven track record in treating prostate cancer, stereotactic radiosurgery, tumor immunotherapy, and lung cancer genetics. He gained his educational background from Shanghai Medical University and University of Southern California/LAC+USC Medical Center. Dr. Lu is not only hands-on in practice but also contributes to medical knowledge through his numerous publications in various reputable journals, which are consistently cited by peers. He has conducted important clinical trials focused on cancer, further demonstrating his commitments in the field. His impeccable work led him to receive the CMS Meaningful Use Stage 1 Certification from Allscripts Enterprise EHR, Allscripts in 2013.
Education & Training
University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Radiation Oncology, 1997 - 2002
Shanghai Medical UniversityClass of 1987
Certifications & Licensure
CA State Medical License 1997 - Present
MO State Medical License 2023 - 2026
NJ State Medical License 2022 - 2023
PA State Medical License 2010 - 2022
TN State Medical License 2002 - 2012
American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2013
Clinical Trials
- Ph I Study of Lithium During Whole Brain Radiotherapy For Patients With Brain Metastases Start of enrollment: 2006 Feb 01
- Measuring Biomarker Response to AMP-514 in Blood Samples From Patients With Solid Tumors Undergoing Radiotherapy Start of enrollment: 2013 Nov 11
- Circulating Tumor DNA in Predicting Outcomes in Patients With Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell Lung Cancer Start of enrollment: 2014 Jul 22
Publications & Presentations
PubMed
- Microglia-Mediated Synaptic Dysfunction Contributes to Chemotherapy-Related Cognitive Impairment.Jingxiong Wang, Hua Zhang, Marc Augenreich, Luis Martinez-Lemus A, Zhenguo Liu
Journal of Neurochemistry. 2025-03-01 - 3 citationsIdentification of dual STRN-NTRK2 rearrangements in a high grade sarcoma, with good clinical response to first-line larotrectinib therapy.Ruihe Lin, Atrayee Basu Mallick, Zi-Xuan Wang, Scot Andrew Brown, Bo Lu
Diagnostic Pathology. 2023-10-21 - The Inherited KRAS-variant as a Biomarker of Cetuximab Response in NSCLC.Joanne B Weidhaas, Chen Hu, Ritsuko Komaki, Gregory A Masters, George R Blumenschein
Cancer Research Communications. 2023-10-11
Press Mentions
Surveys, Dashboards, and Innovations in Response to COVID-19September 1st, 2021
Jefferson Researchers Find Highly Active Gene in Aggressive Human Lung CancerMarch 10th, 2016
Pediatric Trauma Researchers at Ohio State University and Nationwide Children’s Hospital Receive Grant to Develop New Treatment Effects Evaluation MethodOctober 14th, 2015- Join now to see all
Grant Support
- Poly-Matching Causal Inference for Assessing Multiple Acute Medical Managements of Pediatric Traumatic Brain InjuriesRESEARCH INST NATIONWIDE CHILDREN'S HOSP2023–2028
- Poly-Matching Causal Inference for Assessing Multiple Acute Medical Managements of Pediatric Traumatic Brain InjuriesRESEARCH INST NATIONWIDE CHILDREN'S HOSP2023–2028
- Poly-Matching Causal Inference for Assessing Multiple Acute Medical Managements of Pediatric Traumatic Brain InjuriesRESEARCH INST NATIONWIDE CHILDREN'S HOSP2023–2028
- Poly-Matching Causal Inference for Assessing Multiple Acute Medical Managements of Pediatric Traumatic Brain InjuriesRESEARCH INST NATIONWIDE CHILDREN'S HOSP2023–2028
- Poly-Matching Causal Inference for Assessing Multiple Acute Medical Managements of Pediatric Traumatic Brain InjuriesRESEARCH INST NATIONWIDE CHILDREN'S HOSP2023–2028
- Autoimmune toxicities from combined radiotherapy and immunotherapyNCI2021–2026
- Autoimmunity in Cardiopulmonary Toxicities from Radiotherapy andImmunotherapyUNIVERSITY OF MISSOURI-COLUMBIA2020–2026
- Matched Design with Sensitivity Analysis for Observational Survival Data in Cardiovascular Patient Management using EMR DataOHIO STATE UNIVERSITY2023–2025
- Matched Design with Sensitivity Analysis for Observational Survival Data in Cardiovascular Patient Management using EMR DataOHIO STATE UNIVERSITY2023–2025
- Matched Design with Sensitivity Analysis for Observational Survival Data in Cardiovascular Patient Management using EMR DataOHIO STATE UNIVERSITY2023–2025
- Matched Design with Sensitivity Analysis for Observational Survival Data in Cardiovascular Patient Management using EMR DataOHIO STATE UNIVERSITY2023–2025
- Matched Design with Sensitivity Analysis for Observational Survival Data in Cardiovascular Patient Management using EMR DataOHIO STATE UNIVERSITY2023–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
